GH1 and neoplasm: Consistent with our results, the Cancer Genome Atlas project (TCGA) via cBioPortal [27, 28] reported in 206 samples, that 18 (9%) and 13 (6%) tumor samples harbored genomic amplification or mRNA upregulation for hGH or hPRL, respectively.